{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T04:26:51Z","timestamp":1764390411267,"version":"3.46.0"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,11,28]]},"DOI":"10.1248\/bpb.b25-00439","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T22:08:28Z","timestamp":1764281308000},"page":"1822-1829","source":"Crossref","is-referenced-by-count":0,"title":["Incidence of Hepatobiliary Injury in Patients Undergoing Dai-kenchu-to Administration Following Gastrectomy: A Retrospective Cohort Study Using Japanese Diagnosis Procedure Combination Data"],"prefix":"10.1248","volume":"48","author":[{"given":"Yu","family":"Wada","sequence":"first","affiliation":[{"name":"Tsumura Advanced Technology Research Laboratories, Research &amp; Development Division, Tsumura &amp; Co., 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki 300\u20131192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Tsumura Advanced Technology Research Laboratories, Research &amp; Development Division, Tsumura &amp; Co., 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki 300\u20131192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of General and Abdominal Surgery, School of Medicine, University of Occupational and Environmental Health Japan, 1\u20131 Iseigaoka, Yahatanishi-ku, Kitakyushu 807\u20138555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Asakawa","sequence":"additional","affiliation":[{"name":"Tsumura Advanced Technology Research Laboratories, Research &amp; Development Division, Tsumura &amp; Co., 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki 300\u20131192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of General and Abdominal Surgery, School of Medicine, University of Occupational and Environmental Health Japan, 1\u20131 Iseigaoka, Yahatanishi-ku, Kitakyushu 807\u20138555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Fujino","sequence":"additional","affiliation":[{"name":"Environmental Epidemiology, Institute of Industrial and Ecological Sciences, University of Occupational and Environmental Health Japan, 1\u20131 Iseigaoka, Yahatanishi-ku, Kitakyushu 807\u20138555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Manabe N, Camilleri M, Rao A, Wong BS, Burton D, Busciglio I, Zinsmeister AR, Haruma K. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. <i>Am. J. Physiol. Gastrointest. Liver Physiol.<\/i>, <b>298<\/b>, G970\u2013G975 (2010).","DOI":"10.1152\/ajpgi.00043.2010"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Shimada M, Morine Y, Nagano H, Hatano E, Kaiho T, Miyazaki M, Kono T, Kamiyama T, Morita S, Sakamoto J, Kusano M, Saji S, Kanematsu T, Kitajima M. Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001). <i>Int. J. Clin. Oncol.<\/i>, <b>20<\/b>, 95\u2013104 (2015).","DOI":"10.1007\/s10147-014-0678-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Okada K, Kawai M, Hirono S, Fujii T, Kodera Y, Sho M, Nakajima Y, Satoi S, Kwon AH, Shimizu Y, Ambo Y, Kondo N, Murakami Y, Ohuchida J, Eguchi H, Nagano H, Oba MS, Morita S, Sakamoto J, Yamaue H. Evaluation of the efficacy of daikenchuto (TJ-100) for the prevention of paralytic ileus after pancreaticoduodenectomy: a multicenter, double-blind, randomized, placebo-controlled trial. <i>Surgery<\/i>, <b>159<\/b>, 1333\u20131341 (2016).","DOI":"10.1016\/j.surg.2015.11.019"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Yoshikawa K, Shimada M, Wakabayashi G, Ishida K, Kaiho T, Kitagawa Y, Sakamoto J, Shiraishi N, Koeda K, Mochiki E, Saikawa Y, Yamaguchi K, Watanabe M, Morita S, Kitano S, Saji S, Kanematsu T, Kitajima M. Effect of daikenchuto, a traditional Japanese herbal medicine, after total gastrectomy for gastric cancer: a multicenter, randomized, double-blind, placebo-controlled, phase II trial. <i>J. Am. Coll. Surg.<\/i>, <b>221<\/b>, 571\u2013578 (2015).","DOI":"10.1016\/j.jamcollsurg.2015.03.004"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Akamaru Y, Takahashi T, Nishida T, Omori T, Nishikawa K, Mikata S, Yamamura N, Miyazaki S, Noro H, Takiguchi S, Mori M, Doki Y. Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial. <i>J. Gastrointest. Surg.<\/i>, <b>19<\/b>, 467\u2013472 (2015).","DOI":"10.1007\/s11605-014-2730-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hosaka M, Arai I, Ishiura Y, Ito T, Seki Y, Naito T, Masuzawa Y, Nakayama T, Motoo Y. Efficacy of daikenchuto, a traditional Japanese kampo medicine, for postoperative intestinal dysfunction in patients with gastrointestinal cancers: meta-analysis. <i>Int. J. Clin. Oncol.<\/i>, <b>24<\/b>, 1385\u20131396 (2019).","DOI":"10.1007\/s10147-019-01502-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ishizuka M, Shibuya N, Nagata H, Takagi K, Iwasaki Y, Hachiya H, Aoki T, Kubota K. Perioperative administration of traditional Japanese herbal medicine daikenchuto relieves postoperative ileus in patients undergoing surgery for gastrointestinal cancer: a systematic review and meta-analysis. <i>Anticancer Res.<\/i>, <b>37<\/b>, 5967\u20135974 (2017).","DOI":"10.21873\/anticanres.12043"},{"key":"8","unstructured":"8) Ohta K. Kampo in surgery. <i>Surg. Ther<\/i>, <b>97<\/b>, 455\u2013460 (2007)."},{"key":"9","unstructured":"9) Nishi M, Shimada M, Morine Y, Yoshikawa K, Tokunaga T, Nakao T, Kashihara H, Takasu C, Yoshimoto T, Wada Y. Perioperative management support with daikenchuto. <i>Jpn. J. Surg. Metab. Nutr<\/i>, <b>56<\/b>, 59\u201361 (2022)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Luckey A, Livingston E, Tach\u00e9 Y. Mechanisms and treatment of postoperative ileus. <i>Arch. Surg.<\/i>, <b>138<\/b>, 206\u2013214 (2003).","DOI":"10.1001\/archsurg.138.2.206"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Takahashi T, Miyata K, Watanabe M, Yuasa N, Takeuchi E, Goto Y, Miyake H, Nagasawa K, Omori K, Kobayashi Y. Impact of implementation of a clinical pathway for adhesive small bowel obstruction. <i>Nihon Shokaki Geka Gakkai Zasshi<\/i>, <b>43<\/b>, 10\u201319 (2010).","DOI":"10.5833\/jjgs.43.10"},{"key":"12","unstructured":"12) Katori Y, Tsukamoto M, Agenosono H. Investigation of frequency adverse drug reaction to Tsumura daikenchuto extract granules for ethical use in Japan. <i>Prog. Med.<\/i>, <b>32<\/b>, 1973\u20131982 (2012)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Kimura K, Kikegawa M, Kan Y, Uesawa Y. Identifying crude drugs in kampo medicines associated with drug-induced liver injury using the Japanese adverse drug event report database: a comprehensive survey. <i>Pharmaceuticals<\/i>, <b>16<\/b>, 678 (2023).","DOI":"10.3390\/ph16050678"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ghavami A, Ziaei R, Foshati S, Hojati Kermani MA, Zare M, Amani R. Benefits and harms of ginseng supplementation on liver function? A systematic review and meta-analysis. <i>Complement. Ther. Clin. Pract.<\/i>, <b>39<\/b>, 101173 (2020).","DOI":"10.1016\/j.ctcp.2020.101173"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Willetts KE, Ekangaki A, Eden JA. Effect of a ginger extract on pregnancy-induced nausea: a randomised controlled trial. <i>Aust. N. Z. J. Obstet. Gynaecol.<\/i>, <b>43<\/b>, 139\u2013144 (2003).","DOI":"10.1046\/j.0004-8666.2003.00039.x"},{"key":"16","unstructured":"16) Cancer Information Service, National Cancer Center, Japan. (National Cancer Registry, Ministry of Health, Labour and Welfare). \u201cCancer statistics (2016\u20132020).\u201d: &lt;https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/dl\/index.html#a14&gt;, accessed 10 February, 2025."},{"key":"17","unstructured":"17) Ministry of Health, Labour and Welfare. \u201c5th NDB open data (2018).\u201d: &lt;https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177221_00008.html&gt;, accessed 10 February, 2025."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. <i>Md. State Med. J.<\/i>, <b>14<\/b>, 61\u201365 (1965).","DOI":"10.1037\/t02366-000"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kinjo Y, Okabe H, Obama K, Tsunoda S, Tanaka E, Sakai Y. Elevation of liver function tests after laparoscopic gastrectomy using a Nathanson liver retractor. <i>World J. Surg.<\/i>, <b>35<\/b>, 2730\u20132738 (2011).","DOI":"10.1007\/s00268-011-1301-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Jeong GA, Cho GS, Shin EJ, Lee MS, Kim HC, Song OP. Liver function alterations after laparoscopy-assisted gastrectomy for gastric cancer and its clinical significance. <i>World J. Gastroenterol.<\/i>, <b>17<\/b>, 372\u2013378 (2011).","DOI":"10.3748\/wjg.v17.i3.372"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Donati M, Conforti A, Lenti MC, Capuano A, Bortolami O, Motola D, Moretti U, Vannacci A, Rafaniello C, Vaccheri A, Arzenton E, Bonaiuti R, Sportiello L, Leone R. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy. <i>Br. J. Clin. Pharmacol.<\/i>, <b>82<\/b>, 238\u2013248 (2016).","DOI":"10.1111\/bcp.12938"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sabat\u00e9 M, Ib\u00e1\u00f1ez L, P\u00e9rez E, Vidal X, Buti M, Xiol X, Mas A, Guarner C, Forn\u00e9 M, Sol\u00e0 R, Castellote J, Rigau J, Laporte JR. Risk of acute liver injury associated with the use of drugs: a multicentre population survey. <i>Aliment. Pharmacol. Ther.<\/i>, <b>25<\/b>, 1401\u20131409 (2007).","DOI":"10.1111\/j.1365-2036.2007.03338.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Sumiyoshi S, Kubota T, Ohashi T, Nishibeppu K, Kiuchi J, Shimizu H, Arita T, Yamamoto Y, Konishi H, Morimura R, Kuriu Y, Shiozaki A, Ikoma H, Fujiwara H, Otsuji E. Risk factors for liver dysfunction and their clinical importance after gastric cancer surgery. <i>Sci. Rep.<\/i>, <b>14<\/b>, 8076 (2024).","DOI":"10.1038\/s41598-024-58644-0"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Sano A, Saito K, Kuriyama K, Nakazawa N, Ubukata Y, Hara K, Sakai M, Ogata K, Fukasawa T, Sohda M, Fukuchi M, Naitoh H, Shirabe K, Saeki H. Risk factors for postoperative liver enzyme elevation after laparoscopic gastrectomy for gastric cancer. <i>In Vivo<\/i>, <b>35<\/b>, 1227\u20131234 (2021).","DOI":"10.21873\/invivo.12373"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Kaida S, Murakami Y, Ohta S, Yamaguchi T, Takebayashi K, Murata S, Nitta N, Shimizu T, Tani M. A novel technique to predict liver damage after laparoscopic gastrectomy from the stomach volume overlapping the liver by preoperative computed tomography. <i>World J. Surg.<\/i>, <b>44<\/b>, 3052\u20133060 (2020).","DOI":"10.1007\/s00268-020-05584-1"},{"key":"26","unstructured":"26) Jacob C. <i>Statistical power analysis for the behavioral sciences<\/i>. 2nd ed., Routledge, New York (1988)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Okovityi SV, Raikhelson KL, Prikhodko VA. Combined hepatoprotective pharmacotherapy for liver disease. <i>Eksp. Klin. Gastroenterol.<\/i>, <b>7<\/b>, 5\u201320 (2022).","DOI":"10.31146\/1682-8658-ecg-203-7-5-20"},{"key":"28","unstructured":"28) Huang G, Wang Y. Pharmacoeconomic profiles of four hepatoprotective drugs used for the treatment of drug-induced liver injury. <i>Zhonghua Gan Zang Bing Za Zhi<\/i>, <b>22<\/b>, 763\u2013768 (2014)."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Dakhoul L, Vuppalanchi R. The causes and clinical spectrum of drug-induced cholestatic liver injury. <i>Curr. Hepatol. Rep.<\/i>, <b>16<\/b>, 130\u2013136 (2017).","DOI":"10.1007\/s11901-017-0347-9"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Li M, Luo Q, Tao Y, Sun X, Liu C. Pharmacotherapies for drug-induced liver injury: a current literature review. <i>Front. Pharmacol.<\/i>, <b>12<\/b>, 806249 (2022).","DOI":"10.3389\/fphar.2021.806249"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Bessone F, Hillotte GL, Tamagnone N, Arnedillo D, Roma MG. Ursodeoxycholic acid for the management of drug-induced liver injury: role of hepatoprotective and anti-cholestatic mechanisms. <i>J. Clin. Transl. Hepatol.<\/i>, <b>13<\/b>, 162\u2013168 (2025).","DOI":"10.14218\/JCTH.2024.00325"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Thabrew MI, Hughes RD. Phytogenic agents in the therapy of liver disease. <i>Phytother. Res.<\/i>, <b>10<\/b>, 461\u2013467 (1996).","DOI":"10.1002\/(SICI)1099-1573(199609)10:6<461::AID-PTR899>3.0.CO;2-V"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. <i>Drug Alcohol Rev.<\/i>, <b>29<\/b>, 437\u2013445 (2010).","DOI":"10.1111\/j.1465-3362.2009.00153.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, Lee R, Neuman MG, Rehm J. Alcohol consumption and risk of liver cirrhosis: a systematic review and meta-analysis. <i>Am. J. Gastroenterol.<\/i>, <b>114<\/b>, 1574\u20131586 (2019).","DOI":"10.14309\/ajg.0000000000000340"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Bj\u00f6rnsson HK, Bj\u00f6rnsson ES. Review of human risk factors for idiosyncratic drug-induced liver injury: latest advances and future goals. <i>Expert Opin. Drug Metab. Toxicol.<\/i>, <b>19<\/b>, 969\u2013977 (2023).","DOI":"10.1080\/17425255.2023.2288260"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/11\/48_b25-00439\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:24:15Z","timestamp":1764386655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/11\/48_b25-00439\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00439","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"article-number":"b25-00439"}}